June

June 30, 2014

Natural product-based therapy for Metastatic Melanoma: 1α,25-dihydroxyvitamin D(3) increases the expression of RNA-editing enzyme ADAR1 (Adenosine Deaminase Acting on RNA) via down regulation of its target gene, 01/July/2014, 5.24 am

A study from the Ella Institute of Melanoma, Ramat-Gan, Israel has reported that “MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth.” This study was published in the […]
June 30, 2014

Natural product-based Cancer therapy: 6-Gingerol inhibits leukemia proliferation via down regulation of cell cycle-regulated protein CCNA2, 1/July/2014, 5.06 am

Idea Proposed/Formulated by: Dr L Boominathan PhD Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, Natural product-based Cancer therapy: 6-Gingerol  inhibits leukemia proliferation via down regulation of cell cycle-regulated protein CCNA2, […]
June 30, 2014

MiRNAs-based Comination therapy for Hepatocellular carcinoma: miRNA-375 and miRNA-29b inhibit Hepatocarcionogenesis progression via down regulation of their target genes, 1/July/2014,4.51 am

Idea Proposed/Formulated by: Dr L Boominathan PhD Web: http://genomediscovery.org Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/ To cite: Boominathan, MiRNAs-based Comination therapy for Hepatocellular carcinoma: miRNA-375 and miRNA-29b inhibit Hepatocarcionogenesis progression via down regulation […]
June 30, 2014

Molecular cancer therapy: IL-1β inhibits cancer development by suppressing the expression of nucleotide sanitizing enzyme MTH1/NUDT1, 30/June/2014, 15.03

A study from Karolinska Institutet, Stockholm, Sweden shows that MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.  This study was published in the April 10, 2014 Nature [I.F >35] by Prof. Thomas H, […]